Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-031159)

Filing Details

Accession Number:: 0001209191-17-031159
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-10 12:52:21
Reporting Period:: 2017-05-09

Filing Date:: 2017-05-10
Accepted Time:: 2017-05-10 12:52:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510580	Kite Pharma Inc.	KITE	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1569002	B Steven Ruchefsky	C/O Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-09	1,400	$69.50	225,426	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Includes 136,038 shares, previously registered in the name of Commercial Street Capital, LLC, which were distributed to the Reporting Person on April 3, 2017 in a pro rata distribution and are now owned directly.